Stay updated on PD-1 and Cell Therapy in NSCLC Clinical Trial
Sign up to get notified when there's something new on the PD-1 and Cell Therapy in NSCLC Clinical Trial page.
Latest updates to the PD-1 and Cell Therapy in NSCLC Clinical Trial page
- Check4 days agoChange DetectedThe page shows minor administrative updates, including a refreshed last update date and light formatting changes. Core study details and eligibility remain unchanged.SummaryDifference0.5%
- Check11 days agoNo Change Detected
- Check33 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference4%
- Check40 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%
- Check54 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; removed the Back to Top element. No other substantive changes.SummaryDifference0.3%
- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.3%
- Check69 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, while removing specific geographic details and references to MedlinePlus Genetics. Notably, terms related to lung cancer and relevant medical classifications have been added.SummaryDifference3%
Stay in the know with updates to PD-1 and Cell Therapy in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PD-1 and Cell Therapy in NSCLC Clinical Trial page.